University of Vermont Medical Center; Investigational Drug Service, Pharmacy Department/Baird 1 — Burlington, Vermont

University of Vermont Medical Center; Investigational Drug Service, Pharmacy Department/Baird 1 is a clinical research site located in Burlington, Vermont, United States 05401.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of Vermont Medical Center; Investigational Drug Service, Pharmacy Department/Baird 1 has participated in 1 clinical trials.

Therapeutic areas: Diabetic Macular Edema.

Sponsors: Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Vermont Medical Center; Investigational Drug Service, Pharmacy Department/Baird 1?

University of Vermont Medical Center; Investigational Drug Service, Pharmacy Department/Baird 1 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Vermont Medical Center; Investigational Drug Service, Pharmacy Department/Baird 1 conducted?

University of Vermont Medical Center; Investigational Drug Service, Pharmacy Department/Baird 1 has 1 clinical trials on record. Their work covers Diabetic Macular Edema.

Is University of Vermont Medical Center; Investigational Drug Service, Pharmacy Department/Baird 1 accredited by Crixeo Health?

University of Vermont Medical Center; Investigational Drug Service, Pharmacy Department/Baird 1 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Vermont Medical Center; Investigational Drug Service, Pharmacy Department/Baird 1?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.